The Government is expected to perform a U-turn in the budget by scrapping plans to impose a capital gains tax (CGT) liability ...

Novartis CEO Vas Narasimhan stated that the company will not compete in the "frenzy" of the weight loss drug market dominated ...

Here are 10 of the best health care stocks to buy in 2024, according to CFRA analysts: *As of Sept. 10 close. Based on ...

“Having a medication for that age group, if approved, would be a really nice tool to have, but we're also going to have to be ...

Haya could secure up to $1bn after hitting preclinical, clinical, and commercial milestones with drugs that emerge from this deal.

Many HCPs now place greater importance on pharmaceutical companies that integrate patients within the continuum of care.

Many of the industry’s glitzy new buildings are showcasing impressive artwork by artists dealing with homelessness or living ...

Eli Lilly is the clear frontrunner to be the largest pharmaceutical stock in 2034. See what its prospects are for the next ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 586.36% and ...

Just over a year after launching with $33 million in seed funding, Boston-based Superluminal Medicines is supercharging its ...

Four years after launching a remote-controlled robotic laboratory in San Diego, Eli Lilly is shipping the operation overseas.

Two new papers by a team of researchers at Boston University, the Indiana University School of Medicine and the Alzheimer’s Disease Neuroimaging Initiative (ADNI), and the German Center for ...